Precision oncology platform combining molecular profiling, AI, and EHR integration
Caris Life Sciences is a TechBio company built on comprehensive genomic sequencing (whole exome and transcriptome), machine learning, and clinical databases to power precision medicine diagnostics and therapy selection, primarily in oncology. The hiring velocity is accelerating across sales (65 open roles) and healthcare (33), while engineering and research remain smaller teams—a pattern typical of clinical-stage companies scaling go-to-market and payer reimbursement ahead of product R&D. Active projects cluster heavily around EHR integration, payer adoption, and point-of-care deployment, revealing friction points in translating molecular insights into clinical workflows.
Notable leadership hires: Biopharma Business Development Lead, Medical Director, Market Access Director, Regional Business Director, Strategic Accounts Director
Caris Life Sciences develops precision medicine solutions centered on molecular profiling and AI-driven analysis for cancer diagnosis, monitoring, and therapy selection. Founded in 1996 and headquartered in Irving, Texas, the company operates with 1,001–5,000 employees across offices in Phoenix, New York, Tokyo, and Basel, serving U.S., European, Asian, and international markets through direct sales and distributor partnerships. The product layer includes companion diagnostics, oncology workflow tools, and a clinico-genomic database. Current operational focus spans regulatory submissions for NGS-based diagnostics, EHR integration for priority accounts, payer medical policy acceptance, and point-of-care solution rollout—indicating a phase of clinical adoption and reimbursement maturation rather than early research.
Core: Java, Spring Boot, Python, Node.js, React, Vue, Next.js. Cloud: AWS, GCP, Azure. Data/monitoring: Oracle, SQL, Datadog, Grafana, New Relic. DevOps: Docker, Kubernetes. Enterprise: Salesforce, Microsoft Office suite, Windows/macOS with Intune, JAMF Pro.
Primary initiatives: EHR integration for oncology workflows, regulatory submissions for NGS companion diagnostics, payer medical policy acceptance, point-of-care solution deployment, precision oncology program optimization, and data management strategy. Also scaling adoption of molecular profiling solutions across healthcare systems.
Other companies in the same industry, closest in size